ATE451100T1 - Pharmazeutische wundheilungszusammensetzungen in form einer crome auf basis von aminosäuren und natriumhyaluronat - Google Patents

Pharmazeutische wundheilungszusammensetzungen in form einer crome auf basis von aminosäuren und natriumhyaluronat

Info

Publication number
ATE451100T1
ATE451100T1 AT06806303T AT06806303T ATE451100T1 AT E451100 T1 ATE451100 T1 AT E451100T1 AT 06806303 T AT06806303 T AT 06806303T AT 06806303 T AT06806303 T AT 06806303T AT E451100 T1 ATE451100 T1 AT E451100T1
Authority
AT
Austria
Prior art keywords
amino acids
sodium hyaluronate
crome
wound healing
healing compositions
Prior art date
Application number
AT06806303T
Other languages
English (en)
Inventor
Franco Conti
Original Assignee
Solartium Entpr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37696025&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE451100(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Solartium Entpr Ltd filed Critical Solartium Entpr Ltd
Application granted granted Critical
Publication of ATE451100T1 publication Critical patent/ATE451100T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AT06806303T 2005-10-26 2006-10-16 Pharmazeutische wundheilungszusammensetzungen in form einer crome auf basis von aminosäuren und natriumhyaluronat ATE451100T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002035A ITMI20052035A1 (it) 2005-10-26 2005-10-26 Composizioni farmaceutiche cicatrizzanti sotto forma di crema a base di amminoacidi e sodio ialuronato
PCT/EP2006/009966 WO2007048522A1 (en) 2005-10-26 2006-10-16 Wound-healing pharmaceutical compositions in the form of a cream based on amino acids and sodium hyaluronate

Publications (1)

Publication Number Publication Date
ATE451100T1 true ATE451100T1 (de) 2009-12-15

Family

ID=37696025

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06806303T ATE451100T1 (de) 2005-10-26 2006-10-16 Pharmazeutische wundheilungszusammensetzungen in form einer crome auf basis von aminosäuren und natriumhyaluronat

Country Status (11)

Country Link
US (2) US20080287392A1 (de)
EP (1) EP1951219B1 (de)
JP (1) JP5203955B2 (de)
KR (1) KR101583746B1 (de)
AT (1) ATE451100T1 (de)
CA (1) CA2627214C (de)
DE (1) DE602006011048D1 (de)
ES (1) ES2335436T3 (de)
IT (1) ITMI20052035A1 (de)
PL (1) PL1951219T3 (de)
WO (1) WO2007048522A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20052036A1 (it) * 2005-10-26 2007-04-27 Professional Dietetics Srl Composizioni farmaceutiche oftalmiche a base di amminoacidi e sodio ialuronato
ITMI20052037A1 (it) * 2005-10-26 2007-04-27 Professional Dietetics Srl Composizioni farmaceutiche cicatrizzanti sotto forma di polvere sterile a base di amminoacidi e sodio ialuronato
ITMI20052035A1 (it) * 2005-10-26 2007-04-27 Professional Dietetics Srl Composizioni farmaceutiche cicatrizzanti sotto forma di crema a base di amminoacidi e sodio ialuronato
IT1396935B1 (it) 2009-11-26 2012-12-20 Solartium Entpr Ltd Uso di una combinazione per il trattamento delle mucositi indotte da radiazioni o da chemioterapici
ITMI20110954A1 (it) * 2011-05-26 2012-11-27 Professional Dietetics Srl Combinazioni per il trattamento delle mucositi vaginali o rettali
US8642665B2 (en) 2011-12-16 2014-02-04 Conopco, Inc. Environmentally friendly, low whitening compositions
US20150252120A1 (en) 2012-10-09 2015-09-10 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Modified hyaluronic acid derivatives and use thereof
WO2014093645A2 (en) * 2012-12-13 2014-06-19 Precision Dermatology, Inc. Topical formulations for increasing the dermal concentration of hyaluronic acid
GR1008308B (el) 2013-05-31 2014-10-02 UNI-PHARMA ΚΛΕΩΝ ΤΣΕΤΗΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "UNI-PHARMA ABEE", Τοπικες φαρμακευτικες και ιατροτεχνολογικες συνθεσεις που περιεχουν συνδυασμους σουκραλφατης, υαλουρονικου οξεος, αργινινης και ενος φυσικου ενυδατικου παραγοντα
ITMI20131660A1 (it) 2013-10-08 2015-04-09 Professional Dietetics Srl Uso di una combinazione per la prevenzione delle mucositi indotte da radiazioni o da chemioterapici
US10272059B2 (en) 2014-12-04 2019-04-30 Professional Dietetics S.P.A. Aminoacid-based composition for fibroelastin recovery in dermal connective tissues
WO2019232031A1 (en) 2018-05-29 2019-12-05 Mary Kay Inc. Topical compositions and methods
KR20200047220A (ko) 2018-10-27 2020-05-07 장정훈 창상, 당뇨병성 족부/손 궤양 또는 버거씨병 치료용 약학 조성물
KR102072948B1 (ko) 2019-08-06 2020-02-04 주식회사 씨엔엘바이오텍 염증치료용 약학적 발효 조성물
KR102072947B1 (ko) 2019-08-06 2020-02-04 주식회사 씨엔엘바이오텍 상처치유 또는 피부재생 촉진용 약학 조성물
WO2021191811A1 (en) 2020-03-24 2021-09-30 Acupharm Investments (Pty) Limited A novel wound gel composition
KR102226810B1 (ko) * 2020-09-02 2021-03-15 주식회사 엘라스틱랩 연결 조직 중 엘라스틴 및 콜라겐 생합성 증진용 조성물
IT202100023921A1 (it) * 2021-09-21 2023-03-21 Casadei Elena Francesca Composizione per il trattamento analgesico e riepitelizzante del tessuto vulvo-vaginale e perineale.
JP2025536011A (ja) * 2022-11-02 2025-10-30 エルジー・エイチアンドエイチ・カンパニー・リミテッド 皮膚改善用複合体
EP4574145A1 (de) 2023-12-21 2025-06-25 Paul Hartmann Aktiengesellschaft Zusammensetzung mit aminosäuren, metabolisierbarer komponente und lipidkomponente
IT202400006397A1 (it) * 2024-03-22 2025-09-22 The Wave Innovation Group S R L Una composizione a base di acido ialuronico e amminoacidi per l’uso nel trattamento di ferite paradontali

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707354A (en) * 1985-06-17 1987-11-17 Alpen Tau, Inc. Mature skin treatment and protectant compositions and methods of using same
IT1240316B (it) * 1990-02-21 1993-12-07 Ricerca Di Schiena Del Dr. Michele G. Di Schiema & C. Composizioni a base di acido ialuronico ad alto peso molecolare somministrabili per via topica per il trattamento di infiammazioni del cavo orale ,per la cosmetica e l'igiene del cavo orale
WO1996003158A1 (en) * 1994-07-22 1996-02-08 Alcon Laboratories, Inc. Use of low molecular weight amino acids in ophthalmic compositions
US6541460B2 (en) * 1996-08-07 2003-04-01 George D. Petito Method for use of hyaluronic acid in wound management
US6645948B2 (en) * 1998-03-24 2003-11-11 George D. Petito Nutritional composition for the treatment of connective tissue
IT1304191B1 (it) * 1998-12-18 2001-03-08 Solartium Establishment Composizione farmaceutica a base di prolina, glicina e lisina utilenella terapia odontoiatrica sia sotto forma iniettabile che in
IT1318556B1 (it) * 2000-06-07 2003-08-27 Solartium Establishment Composizione farmaceutica a base di prolina, glicina e lisina utilenella terapia per la cicatrizzazione delle ferite e delle lesioni
FR2820635B1 (fr) * 2001-02-09 2005-01-21 Genevrier Lab Procede de preparation d'une creme a base d'acide hyaluronique
ITTO20010804A1 (it) * 2001-08-08 2003-02-08 Professional Dietetics Srl Composizioni a base di aminoacidi, idonee alla terapia per la cicatrizzazione e/o riparazione di ferite e lesioni, in particolare per l'appl
US20040265268A1 (en) * 2001-08-18 2004-12-30 Deepak Jain Compositions and methods for skin rejuvenation and repair
US6780841B2 (en) * 2001-11-13 2004-08-24 Biocell Technology, Llc Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same
US20040180025A1 (en) * 2003-03-12 2004-09-16 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
FR2864445B1 (fr) * 2003-12-30 2006-04-28 Jean Noel Thorel Utilisation topique d'une base nutritive complexe
ITMI20052035A1 (it) 2005-10-26 2007-04-27 Professional Dietetics Srl Composizioni farmaceutiche cicatrizzanti sotto forma di crema a base di amminoacidi e sodio ialuronato
ITMI20052037A1 (it) * 2005-10-26 2007-04-27 Professional Dietetics Srl Composizioni farmaceutiche cicatrizzanti sotto forma di polvere sterile a base di amminoacidi e sodio ialuronato
ITMI20052036A1 (it) * 2005-10-26 2007-04-27 Professional Dietetics Srl Composizioni farmaceutiche oftalmiche a base di amminoacidi e sodio ialuronato

Also Published As

Publication number Publication date
KR101583746B1 (ko) 2016-01-19
JP5203955B2 (ja) 2013-06-05
EP1951219A1 (de) 2008-08-06
CA2627214C (en) 2015-03-10
US20110071105A1 (en) 2011-03-24
US20080287392A1 (en) 2008-11-20
EP1951219B1 (de) 2009-12-09
ITMI20052035A1 (it) 2007-04-27
DE602006011048D1 (de) 2010-01-21
CA2627214A1 (en) 2007-05-03
US8404661B2 (en) 2013-03-26
PL1951219T3 (pl) 2010-05-31
JP2009513585A (ja) 2009-04-02
KR20080068027A (ko) 2008-07-22
WO2007048522A1 (en) 2007-05-03
ES2335436T3 (es) 2010-03-26

Similar Documents

Publication Publication Date Title
DE602006011048D1 (de) Orm einer creme auf basis von aminosäuren und natriumhyaluronat
ATE451916T1 (de) Ophthalmische pharmazeutische zusammensetzungen auf basis von aminosäuren und natriumhyaluronat
ATE350010T1 (de) Zusammensetzung zur topischen anwendung
WO2004012650A3 (fr) Compositions cosmetiques ou dermopharmaceutiques comprenant du kombucha.
WO2006136607A3 (de) Verwendung von hydrophobin-polypeptiden sowie konjugaten aus hydrophobin-polypeptiden mit wirk- oder effektstoffen und ihre herstellung sowie deren einsatz in der kosmetik
WO2008118017A3 (en) Prame derived peptides and immunogenic compositions comprising these
WO2008139122A3 (fr) Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
DE602008002693D1 (de) Vakzine-peptid-kombinationen gegen katzenallergie
ATE355104T1 (de) Haarbehandlungsmittel
BRPI0718615B8 (pt) processo para produzir um material elástico a partir de tropoelastina e material elástico
CY1116264T1 (el) Αντισωματα κατα ανθρωπινης αγγειοποιητινης 2
ATE458746T1 (de) Melphalan-derivate und ihre verwendung als chemotherapeutika gegen krebs
CY1109733T1 (el) Χρησιμοποιηση πολυαιθυλενο γλυκολης για τη θεραπεια παθησεων ασθενειων και τραυματων, που εχουν σχεση με φλεγμονη
CY1115961T1 (el) Ανυδρη μορφη κρυσταλλικης μηλεϊνικης ορβεπιταντης (orvepitant maleate)
CY1118967T1 (el) Φαρμακευτικες συνθεσεις υψηλης δοσης βιοτινης
WO2007100874A3 (en) Compositions containing peptides with non-natural amino acids and methods of use
ITMI20030385A1 (it) Composizione cosmetica comprendente poliisoprene.
WO2008148966A3 (fr) Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
DE602004022772D1 (de) Ausrichtung von enhancernn in kosmetikzusammensetzungen
DE60307665D1 (de) Haarbehandlungszusammensetzungen mit xanthin und alpha-hydroxysäure
DE60226962D1 (de) Pharmazeutische zusammensetzung auf der basis von azaliden für lokale anwendung in der ophtalmologie
ATE498413T1 (de) Pharmazeutische wundheilungs-zusammensetzungen in form eines sterilen pulvers auf basis von aminosäuren und natriumhyaluronat
WO2008129180A3 (fr) Nouveaux facteurs viii pour le traitement des hemophiles de type a
EA200602002A1 (ru) Применение спинозинов для заживления ран
CL2008000707A1 (es) Conjugado de polipeptidos antifusogenicos y polipeptidos derivados de la cabeza globular del factor del complemento c1q; composicion farmaceutica que lo comprende; su uso para tratar infecciones viricas; y metodo de produccion.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties